SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 70 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,068,375 | -11.3% | 46,210 | +0.6% | 0.01% | -10.0% |
Q2 2023 | $1,204,993 | +13.7% | 45,957 | +11.6% | 0.01% | +11.1% |
Q1 2023 | $1,059,973 | -3.6% | 41,180 | -2.6% | 0.01% | -10.0% |
Q4 2022 | $1,099,885 | +43.0% | 42,287 | +57.0% | 0.01% | +42.9% |
Q3 2022 | $769,000 | +6.5% | 26,940 | -8.1% | 0.01% | 0.0% |
Q2 2022 | $722,000 | -74.8% | 29,308 | -42.2% | 0.01% | -77.4% |
Q1 2022 | $2,862,000 | -19.0% | 50,715 | -11.0% | 0.03% | -22.5% |
Q4 2021 | $3,532,000 | -7.5% | 56,990 | -5.4% | 0.04% | +8.1% |
Q3 2021 | $3,820,000 | -27.9% | 60,214 | -6.4% | 0.04% | -21.3% |
Q2 2021 | $5,300,000 | -18.3% | 64,316 | -27.1% | 0.05% | -25.4% |
Q1 2021 | $6,491,000 | +3.3% | 88,231 | +1.9% | 0.06% | -11.3% |
Q4 2020 | $6,281,000 | +140.2% | 86,616 | +57.9% | 0.07% | +86.8% |
Q3 2020 | $2,615,000 | +6.1% | 54,859 | -6.5% | 0.04% | +15.2% |
Q2 2020 | $2,464,000 | +16.7% | 58,673 | -25.0% | 0.03% | 0.0% |
Q1 2020 | $2,111,000 | -36.7% | 78,183 | -9.7% | 0.03% | +26.9% |
Q4 2019 | $3,333,000 | – | 86,603 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |